Skip to main content

Day: May 27, 2020

Masimo and Philips licensing agreement brings Masimo NomoLine® Capnography and O3® Regional Oximetry to select Philips patient monitors

May 27, 2020Amsterdam, the Netherlands and Irvine California – Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG; AEX: PHIA), both global leaders in patient monitoring, announced today that they have reinforced their partnership, whereby Philips will integrate additional Masimo measurement technologies into select IntelliVue® MX-series multi-parameter monitors, to help clinicians assess cerebral oximetry and ventilation status.Core Masimo noninvasive measurements, such as SET® Measure-through Motion and Low Perfusion™ pulse oximetry and advanced rainbow SET® Pulse CO-Oximetry parameters like noninvasive hemoglobin (SpHb®), have long been available on a wide range of Philips multi-parameter monitors.In 2016, Masimo and Philips entered into a multi-year business partnership involving both companies’ innovations in patient monitoring and...

Continue reading

Glory Star New Media Group Holdings Limited Set to Begin Production of the Third Season of Its Flagship Online Variety Show Hello! Rapper

BEIJING, May 27, 2020 (GLOBE NEWSWIRE) — Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) (“Glory Star” or the “Company”), a leading mobile and online digital media and entertainment company in China, today announced that it plans to begin production of the third season of its flagship online variety show Hello! Rapper in June 2020.As one of the first music-centric variety shows in China, the inaugural season of Hello! Rapper was produced by the Company in 2017. Upon its release, the show was an instant online success, collecting over 100 million views in total. In 2019, the Company upgraded the show’s proven content model with the launch of its second season, which consistently ranked as one of the most popular talk shows on third-party video sharing platforms across China during the period. The Company’s content teams...

Continue reading

Cabaletta Bio to Present at Jefferies Virtual Healthcare Conference

PHILADELPHIA, May 27, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President, Chief Executive Officer and Co-Founder, will participate in a fireside chat at the upcoming Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020, at 3:30 p.m. ET.A live webcast of the presentation will be available on the News and Events section of the company’s website at www.cabalettabio.com. Following the presentation, a replay of the webcast will be available on the website for 90 days.About Cabaletta BioCabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered...

Continue reading

ManTech Appoints Peter Ward as Vice President of Human Resources and Talent Acquisition for Mission Solutions and Services (MSS) Group

HERNDON, Va., May 27, 2020 (GLOBE NEWSWIRE) — ManTech (Nasdaq: MANT) today announced that it has appointed Peter Ward as Vice President of Human Resources and Talent Acquisition for the company’s Mission Solutions and Services (MSS) Group.Reporting to Bonnie Cook, Executive Vice President, Operations of MSS, Ward will leverage his two decades of experience in developing outstanding career opportunities to drive the company’s top strategic priority: nationwide recognition of ManTech as the government services contractor industry’s “employer of choice.”“Peter Ward is the perfect match for ManTech’s culture of career enablement,” said Matt Tait, MSS President. “He will apply his proven skills to build on our company’s reputation as the most exciting place to work, and where all share our commitment to Bringing Digital to the Mission®...

Continue reading

Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals

SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today the completion of its previously disclosed merger with Conatus Pharmaceuticals Inc.  The combined company changed its name to Histogen Inc. and will focus on developing patented technologies that replace and regenerate tissues in the body. Histogen is expected to begin trading today, May 27, 2020, on The Nasdaq Capital Market under the ticker symbol “HSTO”. The previous ticker symbol was “CNAT” (Nasdaq: CNAT). Histogen will maintain its headquarters in San Diego, California and will be led by President and Chief Executive Officer, Richard W. Pascoe.“This merger is transformative for Histogen as we look to...

Continue reading

Esperion to Participate in Fireside Chat at the Jefferies Virtual Global Healthcare Conference 2020

ANN ARBOR, Mich., May 27, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR), today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat at the Jefferies Virtual Global Healthcare Conference 2020 on Tuesday, June 2, 2020, at 1:30 p.m. Eastern Time.A live audio webcast of this event can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replay of the webcast will be archived on the Company’s website for 90 days following the event.Esperion TherapeuticsThrough scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on...

Continue reading

Constellium supplies Auto Body Sheet for the new Toyota Corolla in Europe

PARIS, May 27, 2020 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) announced today that it supplies Auto Body Sheet for the new Toyota Corolla produced at Toyota’s European manufacturing plants.Constellium was nominated as the sole supplier of Auto Body Sheet for the hood of the new Corolla, produced at the automaker’s facilities in Burnaston, UK, and Arifiye, Turkey. Toyota is using aluminium for this series on its European production lines for the first time.“We are very proud of this successful collaboration with Toyota and are honored to be supplying one of the world’s best-selling vehicles,” said Dieter Höll, Vice President of Global Automotive Rolled Products at Constellium. “Toyota and Constellium have partnered for many years to develop innovative aluminium solutions for Toyota’s new models, tailored to their manufacturing...

Continue reading

2020 nr. 8 – Sanistål offentliggør kvartalsorientering for 1. kvartal 2020

                                                                                Kontaktperson:                                                                                                                                Adm. direktør                                                                                                                                Christian B. Lund                                                                                                                Tlf. 96 30 60 00Aalborg, den 27. maj 2020Bestyrelsen har i dag godkendt kvartalsorienteringen for 1. kvartal 2020 (Se vedhæftede fil) med følgende hovedpunkter:Resultaterne i 1. kvartal var påvirket af COVID-19 krisen, blandt andet med forskydninger af salget i Danmark over mod produkter og kunder med lavere marginer.Omsætningen i 1. kvartal faldt 3% til...

Continue reading

DraftKings Announces Redemption of Public Warrants

BOSTON, May 27, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced that it will redeem all of its outstanding public warrants to purchase shares of DraftKings’ Class A common stock that were issued under the Warrant Agreement, dated as of May 10, 2019 (the “Warrant Agreement”), by and among Diamond Eagle Acquisition Corp. and Continental Stock Transfer & Trust Company, as warrant agent and transfer agent (as assigned to and assumed by DraftKings and Computershare Trust Company, N.A., a federally chartered trust company, and Computershare Inc., a Delaware corporation (collectively, “Computershare”), as warrant agent and transfer agent, pursuant to that certain Assignment and Assumption Agreement, dated as of April 23, 2020), and that remain outstanding following 5:00 p.m. New York City time on June 26, 2020...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.